SERUM INHIBIN B AS A DIAGNOSTIC MARKER OF MALE INFERTILITY

Authors

  • Syed Mohsin Manzoor
  • Abdus Sattar
  • Rizwan Hashim
  • Farooq Ahmad Khan
  • Muhammad Younas
  • Asif Ali
  • Muhammad Dilawar
  • Amir Ijaz

Abstract

Background: Infertility affects about 15% of all couples in the world. Approximately 40% of allinfertility cases could be attributed entirely to male factors. Serum inhibin B has emerged as a sensitivemarker of male fertility. Analysis of serum inhibin B reflects the relationship between inhibin B, Sertolicell function and spermatogenesis. Methods: This validation study was conducted to calculate thesensitivity, specificity, positive and negative predictive value of serum inhibin B in diagnosis of maleinfertility, using semen analysis as the gold standard. One hundred and sixty men were included in thestudy, they reported for semen analysis for evaluation of male infertility. Sperm count was done perstandard procedure. Serum inhibin B level was determined by ELISA. Results: Serum inhibin B level80 ρg/ml was regarded as a normal response. The serum inhibin B test had 75% sensitivity, 93.1%specificity, 80.5% PPV and 90.7% NPV. Conclusion: Serum inhibin B has a positive correlation withsperm counts and could be used for evaluation of male infertility as a non-invasive predictor ofspermatogenesis. The sensitivity, specificity and PPV are appropriate for clinical decision making andto avoid unnecessary testicular biopsies.Keywords: Inhibin B, male infertility, sensitivity, specificity, predictive values

References

Sharlip I, Jarow J, Belker A, Lipshultz L, Sigman M, Thomas A,

et al. Best practice policies for male infertility. Fertil Steril

;77: 873– 82.

Turek PJ. Practical approaches to the diagnosis and management

of male infertility. Nat Clin Pract Urol 2005;2:226–38.

Mackay HT. Gynecology. In: Tierney LM, McPhee SJ.

Papadakis MA. Current medical diagnosis and treatment. 42nd ed.

New York: Mc Graw-Hill; 2003.p. 699–733.

Guzick DS, Overstreet JW, Factor-Litvak P, Brazil

CK, Nakajima ST, Coutifaris C, et al. Sperm morphology,

motility, and concentration in fertile and infertile men. N Engl J

Med 2001;345:1388–93.

WHO. Towards more objectivity in diagnosis and management

of male infertility. Int J Androl 1987;7(Suppl):1–53.

Behre HM, Yeung CH, Nieschlag E. Diagnosis of male infertility

and hypogonadism. In: Nieschlag E, Behre HM, (Eds).

Andrology: male reproductive health and dysfunction.

Heidelberg: Springer; 1997.p. 87–114.

Pierik FH, Burdorf A, DeJong FH, Weber RF. Inhibin B: A

novel marker of spermatogenesis. Ann Med 2003;35:12–20.

Krause W, Bohring C. Inhibin B as a marker of spermatogenesis.

A new dimension in andrology. Hautarzt 2002;53(1):5–10.

Burger HG, Igarashi M. Inhibin: Definition and nomenclature,

including related substances. Endocrinol 1988;122:1701–2.

Tyrrell JB, Findling JW, Aron DC. Hypothalamus and pituitary.

In: Greenspan FS, Baxter JD, (Eds). Basic and clinical

endocrinology. 4th ed. New York: Appleton and Lange; 1994.p.

–127.

Anderson RA, Sharpe RM. Regulation of inhibin production in

the human male and its clinical applications. Int J Androl

;23:136–44.

Anderson AM. Inhibin B in the assessment of seminiferous

tubular function. Balliere Best Pract Res Clin Endocrinol Metab

;14:389–97.

J Ayub Med Coll Abbottabad 2012;24(3-4)

http://www.ayubmed.edu.pk/JAMC/24-3/Mohsin.pdf

Meachem SJ, Nieschlag E, Simoni M. Inhibin B in male

reproduction: pathophysiology and clinical relevance. Eur J

Endocrinol 2001;145:561–71.

Wallace EM, Groome NP, Riley SC, Parker AC, Wu FC. Effects

of chemotherapy-induced testicular damage on inhibin,

gonadotropin, and testosterone secretion: a prospective

longitudinal study. J Clin Endocrinol Metab 1997;82:3111–5.

Pierik FH, Vreeburg JTM, Stijnen T, Jong FH, Weber RFA.

Serum inhibin B as a marker of spermatogenesis. J Clin

Endocrinol Metab 1998;83:3110–4.

Andersson A-M, Muller J, Skakkeback NE. Different roles of

prepubertal and postpubertal germ cells and Sertoli cells in the

regulation of serum inhibin B levels. J Clin Endocrinol Metab

;83:4451–8.

Mahmoud AM, Comhaire FH, Depuydt CE. The clinical and

biologic significance of serum inhibins in subfertile men. Reprod

Toxicol 1998;12:591–9.

Bohring C, Krause W. Serum levels of inhibin B in men with

different causes of spermatogenic failure. Andrologia

;31:137–41.

Foresta C, Bettella A, Petraglia F, Pistorello M, Luisi S, Rossato

M. Inhibin B levels in azoospermic subjects with cytologically

characterized testicular pathology. Clin Endocrinol (Oxf)

;50:695–701.

Kolb BA, Stanczyk FZ, Sokol RZ. Serum inhibin B levels in

males with gonadal dysfunction. Fertil Steril 2000;74:234–8.

Hipler UC, Hochheim B, Knoll B, Tittelbach J, Schreiber G.

Serum inhibin B as a marker for spermatogenesis. Arch Androl

;46:217–22.

Anawalt BD, Bebb RA, Matsumoto AM, Groome NP,

Illingworth PJ, McNeilley AS, et al. Serum inhibin level reflect

Sertoli’s cells function in normal men and men with testicular

dysfunction. J Clin Endocrinol Metab 1996;81:3341–5.

Hu YA, Huang YF. A serum marker of spermatogenesis–inhibin

B. Zhonghua Nan Ke Xue 2002;8(1):57–60.

Mahmoud AM, Goemaere S, De Bacquer D, Comhaire FH,

Kaufman JM. Serum inhibin B levels in community-dwelling

elderly men. Clin Endocrinol 2000;53:141–7.

Kumanov P, Nandipati KC, Tomova A, Robeva R, Agarwal A.

Significance of inhibin in reproductive pathophysiology and

current clinical applications. Reprod Biomed Online

;10:786–812.

Pierik FH, Abdesselam SA, Vreeburg JT, Dohle GR, De Jong

FH, Weber RF. Increased serum inhibin B levels after varicocele

treatment. Clin Endocrinol (Oxf) 2001;54:775–80.

Klingmuller D, Haidl G. Inhibin B in men with normal and

disturbed Spermatogenesis. Hum Reprod 1997;112:2376–8.

Bano A, Tahir F, Subhan F, Sultan S, Deepa F, Qayyum M, et al.

A preliminary study of gonadotropin ratios among infertile

Pakistani men. Pak J Med Res 2003;42:188–90.

Jensen TK, Andersson AM, Hjollund NHI, Scheike T, Kolstad

H, Giwercman A, et al. Inhibin B as a serum marker of

spermatogenesis: correlation to differences in sperm

concentration and follicle-stimulating hormone levels. A study of

Danish men. J Clin Endocrinol Metab 1998;82:4059–64.

Anderson AM, Petersson JH, Jorgensen N, Jensen TK,

Shakkeback NE. Serum inhibin B and follicle stimulating

hormone levels as tools in the evaluation of infertile men. J Clin

Endocrinol Metab 2004;89:2873–9.

Anderson RA. Clinical studies: inhibin in the adult male. Mol

Cell Endocrinol 2001;180:109–16.

Anderson AM, Muller J, Skakkebaek NE. Different roles of

prepubertal and postpubertal germ cells and Sertoli cells in the

regulation of serum inhibin B levels. J Clin Endocrinol Metab

;83:4451–8.

Larsen LF, Krausz C, Leffers H, Andersson AM, Carlsen E,

Bangsboell S, et al. Inhibin B: A Marker for the functional state

of the seminiferous epithelium in patients with azoospermia

factor c microdeletions. J Clin Endocrinol Metab

;87(12):5618–24.

Downloads

Published

2012-12-01

Most read articles by the same author(s)

1 2 > >>